https://www.ibtimes.com/pfizer-vaccine-emergency-use-authorization-request-when-will-it-be-available-public-3086180
Save stories to read later or create you own news web site to share with anyone
Notify me when I can create my custom news board
We will not share your email addressAlready on AllSides? Log In
AllSides members can bookmark any article and read it later. Save this article by becoming a member today!
Join AllSides to read, share and understand all perspectives of today's news and issues.
Learn more »AllSides members can instantly post news stories to their own personal page, making it easy to share and discuss information they care about. Become your own publisher by becoming a member today! Learn about My Front Page.
Join AllSides to read, share and understand all perspectives of today's news and issues.
Learn more »
First-round doses of a COVID-19 vaccine by Pfizer could soon start rolling out to the public as Pfizer, the company that developed it, started the process to apply for emergency use authorization with the Food and Drug Administration on Friday.
The company, which announced earlier this month that their vaccine, developed with BioNTech, had an initial 90% efficacy in clinical trials, is applying with the FDA for Emergency Use Authorization. If approved, doses could start to roll out in a first wave by mid-December, CNBC reports.
The announcement also comes...
